Font Size: a A A

The Effect Of Atorvastatin On Vasodilatation Function In The Pulmonary Arteries In Monocrotaline-induced PAH Rats

Posted on:2014-12-20Degree:MasterType:Thesis
Country:ChinaCandidate:Z JiangFull Text:PDF
GTID:2254330392967337Subject:Internal Medicine
Abstract/Summary:PDF Full Text Request
Objective: To examine the effects of different doses of atorvastatin preventivetreatment on the vasodilatation of middle and small pulmonary artery rings inmonocrotaline(MCT)-induced pulmonary hypertensive(PAH) rats.Methods:72Male SD rats were randomly assigned into: normal control (Ctr), PAH,PAH pretreated with low dose of (LAtor) and high dose of (HAtor) atorvastatin (Ator)respectively. PAH was induced by single MCT intraperitoneal (i.p.) injection at adose of40mg/kg. Drug was given by gavage. Rats were sacrified1,2and4weeksafter drug administration. Mean pulmonary artery pressure (mPAP), right ventricularhypertrophy index(RVHI%), acetylcholine(Ach)-induced endothelium-dependentrelaxation (EDdR) and sodium nitroprusside(SNP)-induced endothelium-independentrelaxation(EDiR) were determined. The potency of vascular relaxation was expressedas the pD2.Results: mPAP was significantly higher in PAH rats than that in Ctr4weeks afterMCT injection(PAH:32.19±0.91vs Ctr:14.39±0.35, p<0.01). Pretreated with Ator for4weeks, mPAP was significantly decreased both in LAtorand in HAtorrats as comparedwith PAH rats(LAtor:19.13±1.01, HAtor:17.55±0.20vs PAH:32.19±0.91; p <0.01).RVHI%significantly increased in PAH rats4weeks after MCT i.p.(PAH:56.76±5.86vs Ctr:21.57±2.99, p <0.01).However, it was significantlydecreased4weeks after pretreated with Ator in LAtorand HAtorrats compared withPAH(LAtor:36.09±4.29vs PAH:56.76±5.86,P<0.01; HAtor:28.93±5.08vsPAH:56.76±5.86, p<0.01). Ach-induced EDdR of SPA rings in PAH was notsignificantly decreased1week after MCT injection, but markedly decreased2weeksafter MCT injection(PAH:5.81±0.87vs Ctr:8.33±0.86, p<0.01).While Ach-inducedEDdR was significantly decreased in both LAtorand HAtorrats4weeks after the pretreatment (LAtor:6.51±0.99,HAtor:6.41±0.56vs Ctr:8.33±0.86, p <0.05), but not in1and2weeks. SNP-induced EDiR of SPA rings in PAH was not significantly decreased1or2weeks after MCT injection, but it was significantly decreased4weeks after theinjection (5.89±0.97vs8.53±0.91, p<0.01).There were no difference in EDiR of SPArings among Ctr, LAtorand HAtorrats1week after pretreated with different doses ofAtor. However, Snp-induced EDiR was significantly ameliorated in SPA rings2weeks after the treatment in HAtorrats compared with Ctr rats (9.93±0.78vs8.53±0.91,p<0.01). Snp-induced EDiR was decreased both in LAtorand HAtorrats4weeks after the preventive treatment (6.81±0.76,6.92±0.62vs8.53±0.91, p<0.05).Similar results were observed in isolated MPA rings.Conclusion:Early preventive treatment with low dose of atorvastatin has protectiveeffects on the early damage of endothelium-dependent vasodilatation function insmall and middle pulmonary artery of MCT-induced PAH rats. Both high and lowdose of atorvastatin show preventive effects on EDiR in SPA, but early protectiveeffect was only shown in high dose.
Keywords/Search Tags:monocrotaline, pulmonary hypertension, atorvastatin, vasodilatation
PDF Full Text Request
Related items